Menopause treatment market grows despite skepticism

A growing market for unconventional treatments for menopause is developing, despite medical skepticism and concerns over the lack of scientific validation for many products. The market includes hormone tests, dietary supplements, and testosterone treatments, all of which are often met with caution by health professionals.

Menopause impacts millions in France

In France, menopause affects more than 17 million women over 45 years old, with symptoms such as hot flashes, night sweats, joint pain, and sleep and concentration disorders impacting the quality of life for many. A 2022 study of 5,000 women aged 50 to 65 at the Toulouse University Hospital found that 87% of those without treatment experienced at least one menopause symptom.

Unproven products flood the market

The market for menopause-related products has expanded significantly in recent years, with items such as "dentifrices for menopause," fans, and special pillows being marketed, despite the lack of scientific validation. Professor Florence Trémollières, an endocrinologist and gynecologist, criticized these products as unproven during a recent conference of the French Society of Endocrinology.

Hormone tests and supplements lack evidence

Hormone tests, which analyze blood or urine for hormone levels, are considered "useless" by Dr. Anna Gosset, a medical gynecologist at the specialized center for menopause care at the Toulouse University Hospital, due to fluctuating hormone levels during the menopause transition. Dietary supplements, primarily based on phytoestrogens, are often promoted for symptom relief, but Dr. Gosset notes that none have been the subject of studies confirming their effectiveness.

Testosterone trends raise concerns

Testosterone is another trend, marketed as a "miracle" hormone for hot flashes or fatigue, but international experts have found no solid evidence of these effects except in cases of hypoactive sexual desire disorder (HSDD). Dr. Yveline Ansaldi, a medical gynecologist at the private Saint-Joseph hospital in Paris, notes that no testosterone formulation is currently adapted for menopause treatment, and an overdose can lead to side effects such as acne, increased body hair, hair loss, and potential cardiovascular risks.

Lack of research highlights gaps in care

The lack of scientific research on menopause is a significant concern, with Dr. Ansaldi noting that "there is still progress to be made" in care, particularly in terms of systematic overall health assessments for women during menopause. A 2025 article in the BMJ journal highlighted concerns about the increase in commercial offers for women seeking to alleviate menopause symptoms, noting that "misinformation about menopause harms care."